Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy
Tianchi Yu, Bo Tang, Xueying Sun
Yonsei Medical Journal (2017) Vol. 58, Iss. 3, pp. 489-489
Open Access | Times Cited: 178

Showing 1-25 of 178 citing articles:

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jérôme Galon, Daniela Bruni
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 3, pp. 197-218
Closed Access | Times Cited: 2622
Targeting Tumor Microenvironment for Cancer Therapy
Catarina Roma‐Rodrigues, Rita Mendes, Pedro V. Baptista, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 4, pp. 840-840
Open Access | Times Cited: 1015
Long Non-coding RNA NEAT1: A Novel Target for Diagnosis and Therapy in Human Tumors
Peixin Dong, Ying Xiong, Junming Yue, et al.
Frontiers in Genetics (2018) Vol. 9
Open Access | Times Cited: 221
Hypoxia-Driven Immune Escape in the Tumor Microenvironment
Alyssa Vito, Nader El-Sayes, Karen L. Mossman
Cells (2020) Vol. 9, Iss. 4, pp. 992-992
Open Access | Times Cited: 203
Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
Muhammad Zaeem Noman, Meriem Hasmim, Audrey Lequeux, et al.
Cells (2019) Vol. 8, Iss. 9, pp. 1083-1083
Open Access | Times Cited: 178
Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational Immunotherapy
Yiliang Li, Sapna P. Patel, Jason Roszik, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 175
Targeting iron metabolism in cancer therapy
Michael J. Morales, Xiang Xue
Theranostics (2021) Vol. 11, Iss. 17, pp. 8412-8429
Open Access | Times Cited: 160
Mechanisms of Taxane Resistance
Sara Maloney, Camden A. Hoover, Lorena V. Morejon-Lasso, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3323-3323
Open Access | Times Cited: 145
Functions of the aryl hydrocarbon receptor (AHR) beyond the canonical AHR/ARNT signaling pathway
Natalie C. Sondermann, Sonja Faßbender, Frederick Hartung, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115371-115371
Open Access | Times Cited: 71
Clear Cell Renal Cell Carcinoma: From Biology to Treatment
Adam M. Kase, Daniel J. George, Sundhar Ramalingam
Cancers (2023) Vol. 15, Iss. 3, pp. 665-665
Open Access | Times Cited: 50
Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance
Ting‐Wan Kao, Geng-Hao Bai, Tian‐Li Wang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 46
Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment
Shijiao Zhi, Chen Chen, Hanlin Huang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 16
The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance
Meshach Asare-Werehene, Kiran Nakka, А. А. Реунов, et al.
Oncogene (2019) Vol. 39, Iss. 7, pp. 1600-1616
Open Access | Times Cited: 118
Pathological angiogenesis and inflammation in tissues
Ji-Hak Jeong, Uttam Ojha, You Mie Lee
Archives of Pharmacal Research (2020) Vol. 44, Iss. 1, pp. 1-15
Open Access | Times Cited: 117
Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment
Laurel B. Darragh, Ayman Oweida, Sana D. Karam
Frontiers in Immunology (2019) Vol. 9
Open Access | Times Cited: 106
Autocrine VEGF signalling on M2 macrophages regulates PD‐L1 expression for immunomodulation of T cells
Yin‐Siew Lai, Rika Wahyuningtyas, Shin‐Peir Aui, et al.
Journal of Cellular and Molecular Medicine (2018) Vol. 23, Iss. 2, pp. 1257-1267
Open Access | Times Cited: 86
Flavonoids Targeting HIF-1: Implications on Cancer Metabolism
Marek Samec, Alena Líšková, Lenka Koklesová, et al.
Cancers (2021) Vol. 13, Iss. 1, pp. 130-130
Open Access | Times Cited: 86
Combinatorial therapy in tumor microenvironment: Where do we stand?
Smita Kumari, Dia Advani, Sudhanshu Sharma, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188585-188585
Closed Access | Times Cited: 80
Renal Cell Cancer – Insights in Drug Resistance Mechanisms
HALIMA AWEYS, DEISHA LEWIS, Matin Sheriff, et al.
Anticancer Research (2023) Vol. 43, Iss. 11, pp. 4781-4792
Open Access | Times Cited: 30
Regulation of the HIF switch in human endothelial and cancer cells
Jakub Sławski, Maciej Jaśkiewicz, Anna Barton, et al.
European Journal of Cell Biology (2024) Vol. 103, Iss. 2, pp. 151386-151386
Open Access | Times Cited: 10
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome
Valeria Capaci, Lorenzo Bascetta, Marco Fantuz, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 67
Hypoxia-mediated drug resistance in breast cancers
Courtney E. McAleese, Chandra Choudhury, Neville J. Butcher, et al.
Cancer Letters (2020) Vol. 502, pp. 189-199
Closed Access | Times Cited: 67
Disturbed Flow Increases UBE2C (Ubiquitin E2 Ligase C) via Loss of miR-483-3p, Inducing Aortic Valve Calcification by the pVHL (von Hippel-Lindau Protein) and HIF-1α (Hypoxia-Inducible Factor-1α) Pathway in Endothelial Cells
Joan Fernández Esmerats, Nicolas Villa-Roel, Sandeep Kumar, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2019) Vol. 39, Iss. 3, pp. 467-481
Open Access | Times Cited: 65
Thioredoxin-dependent system. Application of inhibitors
Anna Jastrząb, Elżbieta Skrzydlewska
Journal of Enzyme Inhibition and Medicinal Chemistry (2020) Vol. 36, Iss. 1, pp. 362-371
Open Access | Times Cited: 65
Page 1 - Next Page

Scroll to top